Shares of IXICO plc (LON:IXI – Get Free Report) crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 9.17 ($0.12) and traded as high as GBX 10.75 ($0.14). IXICO shares last traded at GBX 10 ($0.13), with a volume of 137,425 shares changing hands.
IXICO Price Performance
The company has a market capitalization of £5.08 million, a PE ratio of -250.00, a PEG ratio of -0.38 and a beta of 0.86. The firm has a fifty day moving average of GBX 9.17 and a two-hundred day moving average of GBX 8.13. The company has a current ratio of 3.64, a quick ratio of 4.90 and a debt-to-equity ratio of 3.22.
Insider Activity at IXICO
In other IXICO news, insider Mark Warne purchased 26,370 shares of the stock in a transaction on Thursday, October 10th. The stock was acquired at an average price of GBX 9 ($0.11) per share, with a total value of £2,373.30 ($3,008.37). 30.28% of the stock is currently owned by company insiders.
About IXICO
IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company’s technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer.
Read More
- Five stocks we like better than IXICO
- Short Selling: How to Short a Stock
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Applied Materials Market Capitulates: Now is the Time to Buy
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.